Welcome to the Law Firm Disrupted, a briefing from Law.com editor Dan Packel that surveys new competitive pressures on law firms and how their managers are coping, plus insights on the tactics and tech employed by would-be disruptors. Have an opinion? Email me here. Want to be alerted to this dispatch in your inbox every Thursday? Sign up here.
Vito Gagliardi, the chair of New Jersey-based Porzio Bromberg & Newman, bristled just a tiny bit last week when I characterized his firm’s sale of its technology-based, compliance-focused Porzio Life Sciences (PLS) subsidiary to a private equity firm as a “windfall.”